Latest return on equity
Keros Therapeutics Return on equity
Direct answer
Keros Therapeutics's return on equity is -17.16%.
The verified market snapshot reports -17.16%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -17.16%
Explore related company data
View Keros Therapeutics's market capitalizationView Keros Therapeutics's price-to-book ratioView Keros Therapeutics's dividend yieldView Keros Therapeutics's 52-week price rangeView Keros Therapeutics's profit marginView Keros Therapeutics's debt-to-equity ratioView all Keros Therapeutics key metricsReturn to Keros Therapeutics profile